Drug class
Selective prostaglandin E2 (EP2) receptor agonist; ophthalmic intraocular-pressure-lowering agent
Mechanism of action
Omidenepag isopropyl is converted in ocular tissues to omidenepag, a selective EP2 receptor agonist. EP2 activation increases aqueous humour outflow through both conventional and uveoscleral pathways, lowering intraocular pressure.
General use cases
- Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension using the authorised ophthalmic product; indication and availability vary by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
